BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$335M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$270M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$201M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$184M |
| 3 |
Amazon
AMZN
|
+$120M |
| 4 |
Johnson & Johnson
JNJ
|
+$101M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$80.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.45% |
| 2 | Financials | 5.85% |
| 3 | Communication Services | 5.14% |
| 4 | Consumer Discretionary | 4.82% |
| 5 | Healthcare | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWP
3076
DELISTED
Boardwalk Pipeline Partners
BWP
| $110K | ﹤0.01% |
10,851
+10,850
| +1,085,000% | +$129K |
|
3077
Alaunos Therapeutics
TCRT
$4.86M
| $110K | ﹤0.01% |
187
+5
| +3% | +$3.12K |
|
3078
Scorpio Tankers
STNG
$3.93B
| $110K | ﹤0.01% |
5,599
-1,412
| -20% | -$35.8K |
|
3079
PennyMac Financial
PFSI
$4.13B
| $110K | ﹤0.01% |
4,844
-564
| -10% | -$13.1K |
|
3080
Franco-Nevada
FNV
$44.7B
| $109K | ﹤0.01% |
1,600
+900
| +129% | +$65.9K |
|
|
LJPC
3081
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $109K | ﹤0.01% |
3,674
+55
| +2% | +$1.77K |
|
3082
Cato Corp
CATO
$66.7M
| $109K | ﹤0.01% |
7,414
-3,069
| -29% | -$38.8K |
|
3083
Hamilton Lane
HLNE
$5.91B
| $109K | ﹤0.01% |
2,929
+92
| +3% | +$3.38K |
|
|
PERY
3084
DELISTED
Perry Ellis International Inc
PERY
| $108K | ﹤0.01% |
4,202
-3,261
| -44% | -$84.2K |
|
3085
Omeros
OMER
$1.26B
| $108K | ﹤0.01% |
9,704
+164
| +2% | +$2.3K |
|
3086
Rigel Pharmaceuticals
RIGL
$762M
| $108K | ﹤0.01% |
3,055
+51
| +2% | +$2.04K |
|
|
TBRG
3087
DELISTED
TruBridge
TBRG
| $108K | ﹤0.01% |
3,703
-1,303
| -26% | -$39K |
|
3088
Tucows
TCX
$134M
| $108K | ﹤0.01% |
1,930
+36
| +2% | +$2.02K |
|
3089
Hawkins
HWKN
$2.67B
| $108K | ﹤0.01% |
6,124
-2,594
| -30% | -$45.1K |
|
3090
Beazer Homes USA
BZH
$874M
| $107K | ﹤0.01% |
6,734
-64,875
| -91% | -$1.15M |
|
3091
Daktronics
DAKT
$988M
| $107K | ﹤0.01% |
12,141
-3,706
| -23% | -$34.1K |
|
3092
Aqua Metals
AQMS
$10.1M
| $107K | ﹤0.01% |
206
+189
| +1,112% | +$86.7K |
|
|
ROCC
3093
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $106K | ﹤0.01% |
3,026
-23,440
| -89% | -$934K |
|
3094
Karyopharm Therapeutics
KPTI
$45.1M
| $106K | ﹤0.01% |
526
+51
| +11% | +$10.2K |
|
|
BHBK
3095
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $106K | ﹤0.01% |
5,064
-5
| -0.1% | -$101 |
|
3096
PDF Solutions
PDFS
$2.13B
| $105K | ﹤0.01% |
9,030
-2,554
| -22% | -$33.9K |
|
3097
Greenlight Captial
GLRE
$512M
| $105K | ﹤0.01% |
6,546
-2,176
| -25% | -$39.5K |
|
|
GTHX
3098
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $105K | ﹤0.01% |
2,835
+1,045
| +58% | +$27.9K |
|
3099
Cytokinetics
CYTK
$10.2B
| $105K | ﹤0.01% |
14,586
-4,727
| -24% | -$40.5K |
|
|
TAHO
3100
DELISTED
Tahoe Resources Inc
TAHO
| $105K | ﹤0.01% |
+22,319
| New | +$102K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2018 Portfolio in Review
As of Q1 2018, BNP Paribas Financial Markets held 4,465 positions worth $53.4B, down 5.3% from $56.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.87B in Q1 2018, closing 241 positions and reducing 2,365 holdings. Its most notable exit was Calpine Corporation, an estimated $15.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 4.4% a quarter earlier, followed by Financials and Communication Services.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares Russell 2000 Growth ETF worth $95.3M.
- BNP Paribas Financial Markets's largest Q1 2018 buy was iShares Russell 2000 Growth ETF: 500,000 shares worth $95.3M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $1.69B increase.
- BNP Paribas Financial Markets's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $201M.
- BNP Paribas Financial Markets fully exited Calpine Corporation in Q1 2018, selling an estimated $15.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $53.4B portfolio in Q1 2018.
- BNP Paribas Financial Markets opened 229 new positions and closed 241 in Q1 2018.
- BNP Paribas Financial Markets's portfolio value fell 5.3% quarter-over-quarter to $53.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2018, filed 11 May 2018.